EGFR-mutant non-small cell lung cancer
Clinical trials for EGFR-mutant non-small cell lung cancer explained in plain language.
Never miss a new study
Get alerted when new EGFR-mutant non-small cell lung cancer trials appear
Sign up with your email to follow new studies for EGFR-mutant non-small cell lung cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can zapping residual lung cancer spots extend remission?
Disease control Not yet recruitingResearchers are testing whether adding focused radiation to the few remaining cancer spots helps people with advanced EGFR-mutant non-small cell lung cancer live longer without their disease getting worse. Participants first receive a third-generation EGFR-targeted drug plus plat…
Matched conditions: EGFR-MUTANT NON-SMALL CELL LUNG CANCER
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Double-Drug attack: new combo aims to tackle tough lung cancer
Disease control Not yet recruitingThis trial investigates whether combining two drugs—JS212 (given by IV) and JS111 (taken orally)—can safely and effectively shrink tumors in people with advanced non-small cell lung cancer that has a specific EGFR mutation. About 20 participants who have not had prior treatment f…
Matched conditions: EGFR-MUTANT NON-SMALL CELL LUNG CANCER
Sponsor: Huan Zhou • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC